The FDA warned StemGenex Biologic Laboratories about illegally marketing an unapproved stem cell product produced in a facility with significant manufacturing violations, putting patients at risk.
Biologics
CollPlant is a regenerative medicine company focused on 3D bioprinting tissues and organs and developing orthobiologics.
SpinalCyte reported positive 12-month endpoint MRI outcomes in a clinical study of its CybroCell injection for degenerative disc disease.
Tel Aviv (Israel) University researchers generated functional spinal cord, cardiac, cortical and adipogenic tissue implants from personalized hydrogels, according to results detailed in Advanced Materials.
Cellect Biotechnology is a regenerative medicine company.
Bio2 Technologies received FDA approval to begin enrolling patients in an investigational device exemption clinical study to evaluate Vitrium as a cervical interbody fusion device.
Joost de Bruijn, PhD, is the CEO of Kuros Biosciences.
Histogenics develops restorative cell therapies for orthopedic pain relief.
Imagion Biosystems is commercializing a form of medical imaging that uses biosafe nanoparticles to detect cancer, according to Proactive Investors Australia.
Regenerative medicine company SpinalCyte was issued new patents in Hong Kong and Europe.
